EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Dosimetric Evaluation of MR-Guided IMRT and VMAT Techniques for Early-Stage Glottic Cancer: A Pilot Comparative Planning Study

Viktoras Rudžianskas, Evelina Jaselskė iD, Jurgita Laurikaitienė iD, Vita Šimonytė-Verbickienė, Diana Adlienė iD

Medicina · 05.08.2026 · 62 (8) · 1507

DOI: 10.3390/medicina62081507 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Medicina, online erschienen am 05.08.2026. Verfasst von Viktoras Rudžianskas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Institute, Lithuanian University of Health Sciences, Eiveniu str. 2, LT-50161 Kaunas, Lithuania. Hauptthemen laut MEDLINE: Radiotherapy, Intensity-Modulated, Laryngeal Neoplasms, Glottis, Magnetic Resonance Imaging. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Lithuania, Lithuanian Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Early-stage glottic cancer requires highly precise radiotherapy due to laryngeal motion and the proximity of critical structures. Magnetic resonance-guided radiotherapy (MRgRT) enables real-time visualization and motion management, potentially improving dose conformity while reducing treatment margins. This pilot comparative planning study compared the dosimetric characteristics of MR-guided intensity-modulated radiotherapy (IMRT) delivered on the Unity MR-linac with volumetric modulated arc therapy (VMAT) plans generated for the TrueBeam STx and Halcyon systems. Materials and Methods: Ten patients with T1–T2N0 glottic squamous cell carcinoma were included. For each patient, treatment plans prescribing 42.5 Gy in five fractions were generated using all three systems. Planning target volume (PTV) coverage, conformity index (CI), homogeneity index (HI), organ-at-risk (OAR) doses, monitor units, and beam-on times were compared using Friedman and post hoc Wilcoxon signed-rank tests.

Results

Unity achieved superior dose conformity (CI 0.97 ± 0.01 vs. 0.78 ± 0.15 for TrueBeam STx and 0.58 ± 0.19 for Halcyon; p < 0.001) and the highest mean dose, while PTV coverage (D95% and D98%) was comparable to TrueBeam STx and higher than Halcyon. Reduced treatment margins resulted in significantly smaller PTV volumes (11.09 ± 3.87 cm3 vs. 17.43 ± 4.75 cm3; p = 0.0001). Halcyon demonstrated the most homogeneous dose distribution (HI 7.88 ± 3.14), whereas TrueBeam STx showed intermediate homogeneity (HI 12.81 ± 3.90). Most OAR dose metrics were comparable among techniques, although selected laryngeal structures and the esophagus differed significantly. Beam-on time was longest for Unity.

Conclusions

MR-guided IMRT provided superior dose conformity while maintaining target coverage comparable to TrueBeam STx with clinically acceptable OAR sparing. Prospective clinical studies are required to determine whether these dosimetric advantages translate into improved patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiotherapy, Intensity-ModulatedLaryngeal NeoplasmsGlottisMagnetic Resonance ImagingRadiotherapy Planning, Computer-AssistedRadiometryRadiotherapy, Image-GuidedHumansPilot ProjectsRadiotherapy DosageMaleMiddle AgedFemaleAgedCarcinoma, Squamous Cell

Stichwörter der Autor:innen

MR-guided radiotherapyMR-linacdosimetric statisticsglottic cancerindividual treatment planninglaryngeal motion controlorgan at risk sparingstereotactic ablative radiotherapy

Autor:innen und Institutionen

  • Oncology Institute, Lithuanian University of Health Sciences, Eiveniu str. 2, LT-50161 Kaunas, Lithuania.
  • Physics Department, Kaunas University of Technology, Studentu str. 50, LT-51368 Kaunas, Lithuania.

ORCID-Profile: Evelina Jaselskė, Jurgita Laurikaitienė, Diana Adlienė

Förderung

  • Research Council of Lithuania
  • Lithuanian Research Council

Zitieren

APA

Rudžianskas, V., Jaselskė, E., Laurikaitienė, J., Šimonytė-Verbickienė, V., & Adlienė, D. (2026). Dosimetric Evaluation of MR-Guided IMRT and VMAT Techniques for Early-Stage Glottic Cancer: A Pilot Comparative Planning Study. Medicina, 62(8), 1507. https://doi.org/10.3390/medicina62081507

Vancouver

Rudžianskas V, Jaselskė E, Laurikaitienė J, Šimonytė-Verbickienė V, Adlienė D. Dosimetric Evaluation of MR-Guided IMRT and VMAT Techniques for Early-Stage Glottic Cancer: A Pilot Comparative Planning Study. Medicina. 2026;62(8):1507. doi:10.3390/medicina62081507

BibTeX
@article{Rudianskas2026,
  author = {Rudžianskas, Viktoras and Jaselskė, Evelina and Laurikaitienė, Jurgita and Šimonytė-Verbickienė, Vita and Adlienė, Diana},
  title = {Dosimetric Evaluation of MR-Guided IMRT and VMAT Techniques for Early-Stage Glottic Cancer: A Pilot Comparative Planning Study},
  journal = {Medicina},
  year = {2026},
  volume = {62},
  number = {8},
  pages = {1507},
  doi = {10.3390/medicina62081507}
}
Kostenlos starten →